Darren Grady on Food and Drug Administration (FDA)

A Major Step Towards Reform: The DEA Recommends Rescheduling Cannabis

In a recent historic announcement, the U.S. Drug Enforcement Administration has determined that cannabis, which is currently categorized as a Schedule I drug under the Controlled Substances Act (CSA), should be rescheduled to...more

5/1/2024 / Controlled Substances Act , DEA , Decriminalization of Marijuana , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Dispensaries , Food and Drug Administration (FDA) , Marijuana , Marijuana Related Businesses , Medical Marijuana , OMB , Schedule I Drugs

FDA Issues First Ever Guidance for Research of Psychedelics

Earlier this summer, the Food & Drug Administration (FDA) issued draft guidance for those researching the use of psychedelics to treat certain serious medical conditions including major depressive disorder, PTSD, and...more

8/4/2023 / Center for Drug Evaluation and Research (CDER) , Clinical Trials , DEA , Food and Drug Administration (FDA) , Life Sciences , Medical Foods , Pharmaceutical Industry , Research and Development

The Federal Government & CBD – What the FDA is Happening?

Many of us following the ever expanding cannabis industry in the United States have seen more and more CBD-infused food and drink products hitting the market and becoming readily available for consumers. There are CBD...more

1/27/2023 / Cannabidiol (CBD) oil , Cannabis Products , Cannabis-Related Businesses (CRBs) , Dietary Supplements , Food and Drug Administration (FDA) , Marijuana-Infused Edibles , THC

Illinois Lawmaker Introduces Legislation to Legalize Psychedelic Therapy Programs

Last week, La Shawn K. Ford, a Democratic member of the Illinois House of Representatives, introduced the Compassionate Use and Research of Entheogens Act, or CURE Act, as the very first bill during the opening session of...more

1/24/2023 / Compassionate Use Act , Controlled Substances Act , Food and Drug Administration (FDA) , Illinois , Licenses , Manufacturers , Proposed Legislation , PTSD , Research and Development

Federal Cannabis Reform Gaining Momentum: New Legalization Bill Introduced By Republican Congressmen

Today, two Republican Congressmen introduced the “Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act.” Representatives David Joyce (R-OH) Ohio and Don Young (R-AK) are the sponsors of...more

5/14/2021 / Cannabis-Related Businesses (CRBs) , Controlled Substances Act , Decriminalization of Marijuana , Food and Drug Administration (FDA) , Regulatory Reform , U.S. Treasury

FDA Softening Stance On CBD? TBD (Public Hearing On 5/31/19)

While many following the rise of the cannabis industry in the United States have seen CBD-infused food and drink products hitting the market, what many may not know is that CBD-infused products remain illegal at the federal...more

4/4/2019 / Cannabidiol (CBD) oil , Food and Drug Administration (FDA) , Hemp , Marijuana

First FDA Approved Cannabis-Based Medication Clears DEA Hurdle

In June of 2018, in a landmark decision, the FDA issued its first approval of a medicine derived from cannabis, Epidiolex. Manufactured by Britain’s GW Pharmaceuticals, Epidiolex was developed to treat two rare and severe...more

9/28/2018 / DEA , Food and Drug Administration (FDA) , Marijuana , Medical Marijuana , Pharmaceutical Industry

Small Step Or Giant Leap? FDA Approves Cannabis-Derived Drug For The First Time

On June 25, 2018, for the first time in its history, the Food and Drug Administration approved the use of a drug derived directly from cannabis. The drug, called Epidiolex, treats two specific epileptic syndromes – Dravet...more

6/28/2018 / FDA Approval , Food and Drug Administration (FDA) , Marijuana , Medical Marijuana , Pharmaceutical Industry , Prescription Drugs

Darren Grady

Amundsen Davis LLC

Popular Topics by This Author

Latest Posts › Food and Drug Administration (FDA)